Vertex Pharmaceuticals on Track for Record High Close — Data Talk
Vertex Pharmaceuticals Incorporated (VRTX) is currently at $447.15, up $1.94 or 0.44%
--Would be new all-time high (Based on available data back to July 24, 1991)
--Would be first new all-time record closing high since Jan. 30, 2024 when it closed at $446.08
--Currently up 11 of the past 12 days
--Currently up four consecutive days; up 4.33% over this period
--Longest winning streak since May 13, 2024, when it rose for seven straight trading days
--Up 13.83% month-to-date
--Up 9.89% year-to-date
--Up 31.53% from 52 weeks ago (May 22, 2023), when it closed at $339.97
--Would be a new 52-week closing high
--Up 38.19% from its 52-week closing low of $323.57 on May 31, 2023
--Traded as high as $447.58; highest intraday level since Jan. 30, 2024, when it hit $448.40
--Up 0.53% at today's intraday high
All data as of 1:12:44 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 20, 2024 13:30 ET (17:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks